-
1
-
-
0028286627
-
Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling
-
DOI 10.1038/369330a0
-
Nakamura Y, Russell SM, Mess SA et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 1994; 369: 330-333. (Pubitemid 24159545)
-
(1994)
Nature
, vol.369
, Issue.6478
, pp. 330-333
-
-
Nakamura, Y.1
Russell, S.M.2
Mess, S.A.3
Friedmann, M.4
Erdos, M.5
Francois, C.6
Jacques, Y.7
Adelstein, S.8
Leonard, W.J.9
-
2
-
-
0029855513
-
Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases
-
Miyazaki T, Taniguchi T. Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases. Cancer Surv 1996; 27: 25-40. (Pubitemid 26363821)
-
(1996)
Cancer Surveys
, vol.27
, pp. 25-40
-
-
Miyazaki, T.1
Taniguchi, T.2
-
3
-
-
4444323476
-
Interleukin-2 (IL-2) receptor-βγ signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer
-
DOI 10.1016/j.cellsig.2004.03.011, PII S0898656804000518
-
Rocha-Zavaleta L, Huitron C, Caceres-Cortes JR et al. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer. Cell Signal 2004; 16: 1239-1247. (Pubitemid 39165452)
-
(2004)
Cellular Signalling
, vol.16
, Issue.11
, pp. 1239-1247
-
-
Rocha-Zavaleta, L.1
Huitron, C.2
Caceres-Cortes, J.R.3
Alvarado-Moreno, J.A.4
Valle-Mendiola, A.5
Soto-Cruz, I.6
Weiss-Steider, B.7
Rangel-Corona, R.8
-
4
-
-
67449100081
-
Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation
-
Mandelbrot D. Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation. J Am Soc Nephrol 2009; 20: 1170-1171.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1170-1171
-
-
Mandelbrot, D.1
-
5
-
-
0033608073
-
Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin- 2-receptor monoclonal antibody
-
DOI 10.1097/00007890-199901270-00016
-
Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation 1999; 67: 276-284. (Pubitemid 29066355)
-
(1999)
Transplantation
, vol.67
, Issue.2
, pp. 276-284
-
-
Kahan, B.D.1
Rajagopalan, P.R.2
Hall, M.3
-
6
-
-
0035166183
-
Role of anti-interleukin-2 receptor antibodies in kidney transplantation
-
Cibrik DM, Kaplan B, Meier-Kriesche HU. Role of anti-interleukin-2 receptor antibodies in kidney transplantation. BioDrugs 2001; 15: 655-666. (Pubitemid 33078986)
-
(2001)
BioDrugs
, vol.15
, Issue.10
, pp. 655-666
-
-
Cibrik, D.M.1
Kaplan, B.2
Meier-Kriesche, H.-U.3
-
7
-
-
28644435097
-
Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: A review
-
DOI 10.1111/j.1399-0012.2005.00417.x
-
Sandrini S. Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review. Clin Transplant 2005; 19: 705-710. (Pubitemid 41748720)
-
(2005)
Clinical Transplantation
, vol.19
, Issue.6
, pp. 705-710
-
-
Sandrini, S.1
-
8
-
-
34250158081
-
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation
-
Patlolla V, Zhong X, Reed GW et al. Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. Am J Transplant 2007; 7: 1832-1842.
-
(2007)
Am J Transplant
, vol.7
, pp. 1832-1842
-
-
Patlolla, V.1
Zhong, X.2
Reed, G.W.3
-
9
-
-
0442276039
-
A Benefit-Risk Assessment of Basiliximab in Renal Transplantation
-
DOI 10.2165/00002018-200427020-00002
-
Boggi U, Danesi R, Vistoli F et al. A benefit-risk assessment of basiliximab in renal transplantation. Drug Saf 2004; 27: 91-106. (Pubitemid 38186952)
-
(2004)
Drug Safety
, vol.27
, Issue.2
, pp. 91-106
-
-
Boggi, U.1
Danesi, R.2
Vistoli, F.3
Del Chiaro, M.4
Signori, S.5
Marchetti, P.6
Del Tacca, M.7
Mosca, F.8
-
10
-
-
5444256681
-
Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients
-
DOI 10.1111/j.1432-2277.2004.tb00462.x
-
Vincenti F. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transpl Int 2004; 17: 395-401. (Pubitemid 39362567)
-
(2004)
Transplant International
, vol.17
, Issue.8
, pp. 395-401
-
-
Vincenti, F.1
-
11
-
-
0030693070
-
Expression of the IL-2 receptor on human renal proximal tubular epithelial cells
-
Gerritsma JS, Gerritsen AF, van Kooten C et al. Expression of the IL-2 receptor on human renal proximal tubular epithelial cells. J Am Soc Nephrol 1997; 8: 1510-1516. (Pubitemid 27496468)
-
(1997)
Journal of the American Society of Nephrology
, vol.8
, Issue.10
, pp. 1510-1516
-
-
Gerritsma, J.S.J.1
Gerritsen, A.F.2
Van Kooten, C.3
Van Es, L.A.4
Daha, M.R.5
-
12
-
-
16244363668
-
IL-2-mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP
-
DOI 10.1111/j.1523-1755.2005.00217.x
-
Du C, Guan Q, Yin Z et al. IL-2-mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP. Kidney Int 2005; 67: 1397-1409. (Pubitemid 40463116)
-
(2005)
Kidney International
, vol.67
, Issue.4
, pp. 1397-1409
-
-
Du, C.1
Guan, Q.2
Yin, Z.3
Zhong, R.4
Jevnikar, A.M.5
-
13
-
-
0028010818
-
HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney
-
Ryan MJ, Johnson G, Kirk J et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48-57. (Pubitemid 24045991)
-
(1994)
Kidney International
, vol.45
, Issue.1
, pp. 48-57
-
-
Ryan, M.J.1
Johnson, G.2
Kirk, J.3
Fuerstenberg, S.M.4
Zager, R.A.5
Torok-Storb, B.6
-
14
-
-
38149062103
-
Decreased renal ischemia-reperfusion injury by IL-16 inactivation
-
Wang S, Diao H, Guan Q et al. Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int 2008; 73: 318-326.
-
(2008)
Kidney Int
, vol.73
, pp. 318-326
-
-
Wang, S.1
Diao, H.2
Guan, Q.3
-
15
-
-
0025008945
-
MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells
-
Wuthrich RP, Glimcher LH, Yui MA et al. Antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990; 37: 783-792. (Pubitemid 20056852)
-
(1990)
Kidney International
, vol.37
, Issue.2
, pp. 783-792
-
-
Wuthrich, R.P.1
Glimcher, L.H.2
Yui, M.A.3
Jevnikar, A.M.4
Dumas, S.E.5
Kelley, V.E.6
-
17
-
-
0000989863
-
Renal tubular epithelial and T cell interactions in autoimmune renal disease
-
Kelley VR, Diaz-Gallo C, Jevnikar AM et al. Renal tubular epithelial and T cell interactions in autoimmune renal disease. Kidney Int Suppl 1993; 39: S108-S115.
-
(1993)
Kidney Int Suppl
, vol.39
-
-
Kelley, V.R.1
Diaz-Gallo, C.2
Jevnikar, A.M.3
-
18
-
-
33748510411
-
Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury
-
DOI 10.1111/j.1600-6143.2006.01478.x
-
Du C, Wang S, Diao H et al. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemiareperfusion injury. Am J Transplant 2006; 6: 2256-2267. (Pubitemid 44359411)
-
(2006)
American Journal of Transplantation
, vol.6
, Issue.10
, pp. 2256-2267
-
-
Du, C.1
Wang, S.2
Diao, H.3
Guan, Q.4
Zhong, R.5
Jevnikar, A.M.6
-
19
-
-
41749096622
-
Late kidney allograft loss: What we know about it, and what we can do about it
-
Jevnikar AM, Mannon RB. Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol 2008; 3: S56-S67.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
-
-
Jevnikar, A.M.1
Mannon, R.B.2
-
20
-
-
33845656930
-
NOS2 (iNOS) deficiency in kidney donor accelerates allograft loss in a murine model
-
DOI 10.1111/j.1600-6143.2006.01558.x
-
Du C, Jiang J, Guan Q et al. NOS2 (iNOS) deficiency in kidney donor accelerates allograft loss in a murine model. Am J Transplant 2007; 7: 17-26. (Pubitemid 44952852)
-
(2007)
American Journal of Transplantation
, vol.7
, Issue.1
, pp. 17-26
-
-
Du, C.1
Jiang, J.2
Guan, Q.3
Diao, H.4
Yin, Z.5
Wang, S.6
Zhong, R.7
Jevnikar, A.M.8
-
21
-
-
0030984291
-
Acute rejection of renal allografts: Mechanistic insights and therapeutic options
-
Suthanthiran M. Acute rejection of renal allografts: mechanistic insights and therapeutic options. Kidney Int 1997; 51: 1289-1304. (Pubitemid 27186559)
-
(1997)
Kidney International
, vol.51
, Issue.4
, pp. 1289-1304
-
-
Suthanthiran, M.1
-
22
-
-
0035142568
-
Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy
-
Lim CS, Zheng S, Kim YS et al. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 2001; 16: 269-275. (Pubitemid 32123913)
-
(2001)
Nephrology Dialysis Transplantation
, vol.16
, Issue.2
, pp. 269-275
-
-
Lim, C.S.1
Zheng, S.2
Kim, Y.S.3
Ahn, C.4
Han, J.S.5
Kim, S.6
Lee, J.S.7
Chae, D.-W.8
Koo, J.R.9
Chun, R.W.10
Noh, J.W.11
-
23
-
-
0038328852
-
Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis
-
DOI 10.1002/art.11062
-
Chan RW, Tam LS, Li EK et al. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 2003; 48: 1326-1331. (Pubitemid 36554531)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.5
, pp. 1326-1331
-
-
Chan, R.W.-Y.1
Tam, L.-S.2
Li, E.K.-M.3
Lai, F.M.-M.4
Chow, K.-M.5
Lai, K.-B.6
Li, P.K.-T.7
Szeto, C.-C.8
-
24
-
-
0031000670
-
Molecular analyses of human renal allografts: Differential intragraft gene expression during rejection
-
Suthanthiran M. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. Kidney Int Suppl 1997; 58: S15-S21.
-
(1997)
Kidney Int Suppl
, vol.58
-
-
Suthanthiran, M.1
-
25
-
-
26944489293
-
Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury [1]
-
DOI 10.1111/j.1432-2277.2005.00180.x
-
El-Asir L, Wilson CH, Talbot D. Interleukin 2 receptor blockers may directly inhibit lymphocyte mediated ischaemia reperfusion injury. Transpl Int 2005; 18: 1116. (Pubitemid 41726783)
-
(2005)
Transplant International
, vol.18
, Issue.9
, pp. 1116
-
-
El-Asir, L.1
Wilson, C.H.2
Talbot, D.3
-
26
-
-
0028828361
-
Renal expression of interleukin- 2 receptor mRNA in patients with crescentic glomerulonephritis
-
Jenkins DA, Wojtacha DR, Swan P et al. Renal expression of interleukin- 2 receptor mRNA in patients with crescentic glomerulonephritis. Nephron 1995; 71: 303-308.
-
(1995)
Nephron
, vol.71
, pp. 303-308
-
-
Jenkins, D.A.1
Wojtacha, D.R.2
Swan, P.3
-
27
-
-
4744367884
-
Renal tubular epithelial cell self-injury through Fas/Fas ligand interaction promotes renal allograft injury
-
DOI 10.1111/j.1600-6143.2004.00552.x
-
Du C, Jiang J, Guan Q et al. Renal tubular epithelial cell self-injury through Fas/Fas ligand interaction promotes renal allograft injury. Am J Transplant 2004; 4: 1583-1594. (Pubitemid 39312292)
-
(2004)
American Journal of Transplantation
, vol.4
, Issue.10
, pp. 1583-1594
-
-
Du, C.1
Jiang, J.2
Guan, Q.3
Yin, Z.4
Masterson, M.5
Parbtani, A.6
Zhong, R.7
Jevnikar, A.M.8
-
28
-
-
0031850058
-
Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure
-
Schelling JR, Nkemere N, Kopp JB et al. Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 1998; 78: 813-824. (Pubitemid 28347878)
-
(1998)
Laboratory Investigation
, vol.78
, Issue.7
, pp. 813-824
-
-
Schelling, J.R.1
Nkemere, N.2
Kopp, J.B.3
Cleveland, R.P.4
-
29
-
-
39049148397
-
Cellular FLICE-like inhibitory protein (C-FLIP): A novel target for cancer therapy
-
DOI 10.2174/156800908783497087
-
Safa AR, Day TW,Wu CH. Cellular FLICE-like inhibitory protein (CFLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 2008; 8: 37-46. (Pubitemid 351237908)
-
(2008)
Current Cancer Drug Targets
, vol.8
, Issue.1
, pp. 37-46
-
-
Safa, A.R.1
Day, T.W.2
Wu, C.-H.3
-
30
-
-
54249133441
-
FLIP and the death effector domain family
-
Yu JW, Shi Y. FLIP and the death effector domain family. Oncogene 2008; 27: 6216-6227.
-
(2008)
Oncogene
, vol.27
, pp. 6216-6227
-
-
Yu, J.W.1
Shi, Y.2
-
31
-
-
17844361968
-
+ T cell activation through caspase-8-dependent NF-κB activation
-
Dohrman A, Kataoka T, Cuenin S et al. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NFkappa B activation. J Immunol 2005; 174: 5270-5278. (Pubitemid 40593165)
-
(2005)
Journal of Immunology
, vol.174
, Issue.9
, pp. 5270-5278
-
-
Dohrman, A.1
Kataoka, T.2
Cuenin, S.3
Russell, J.Q.4
Tschopp, J.5
Budd, R.C.6
-
32
-
-
34247145009
-
Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model
-
DOI 10.1016/j.canlet.2006.11.013, PII S0304383506006409
-
Zhang L, Zhang X, Barrisford GW et al. Lexatumumab (TRAILreceptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model. Cancer Lett 2007; 251: 146-157. (Pubitemid 46589773)
-
(2007)
Cancer Letters
, vol.251
, Issue.1
, pp. 146-157
-
-
Zhang, L.1
Zhang, X.2
Barrisford, G.W.3
Olumi, A.F.4
-
33
-
-
0037444380
-
Selective Akt inactivation and tumor necrosis factor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel
-
Asakuma J, Sumitomo M, Asano T et al. Selective Akt inactivation and tumor necrosis factor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Cancer Res 2003; 63: 1365-1370. (Pubitemid 36348718)
-
(2003)
Cancer Research
, vol.63
, Issue.6
, pp. 1365-1370
-
-
Asakuma, J.1
Sumitomo, M.2
Asano, T.3
Asano, T.4
Hayakawa, M.5
-
34
-
-
33745187572
-
Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule- derived cell lines commonly used for in vitro toxicity studies
-
Prozialeck WC, Edwards JR, Lamar PC et al. Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule- derived cell lines commonly used for in vitro toxicity studies. Toxicol In Vitro 2006; 20: 942-953
-
(2006)
Toxicol in Vitro
, vol.20
, pp. 942-953
-
-
Prozialeck, W.C.1
Edwards, J.R.2
Lamar, P.C.3
|